NCCN Pharmacy Updates: The Growing Impact of Pharmacogenomics Across the Oncology Landscape
Advances in pharmacogenomics are widespread in the treatment of cancer. The ongoing research in pharmacogenomics has played a vital role in the diagnosis and treatment of oncologic disease states. It is imperative for the interprofessional oncology care team to have a strong understanding of pharmacogenomics and the ability to correctly apply the standard of care for their patients.
Category
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Event date March 18, 2024
Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer
Learn about the results of recent trials, updates to NCCN Guideline recommendations, and common supportive care needs, so that you can provide optimal management for patients with metastatic prostate cancer.
Category
  • Prostate Cancer
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Event date April 26, 2024
Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma
It is important to keep clinicians up to date with NCCN Guidelines for Neuroendocrine and Adrenal Tumors recommendations and with emerging data from clinical studies as this may help optimize treatment selection and ultimately improve clinical outcomes.
Category
  • Neuroendocrine Tumors
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Event date May 9, 2024

Pages